help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pita, J. C.
Right arrow Articles by Loriaux, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pita, J. C., Jr
Right arrow Articles by Loriaux, D. L.

Endocrinology, Vol 97, 1521-1527, Copyright © 1975 by Endocrine Society

ARTICLES

Interaction of spironolactone and digitalis with the 5 alpha- dihydrotestosterone (DHT) receptor of rat ventral prostate

JC Pita Jr, ME Lippman, EB Thompson and DL Loriaux

The aldosterone antagonist, spironolactone, has been shown to block the effects of exogenously administered androgen in rat. This suggests that interaction of the drug with androgen at the target tissues may occur. In this paper we have studied the possible interaction of spironolactone with the 5alpha-dihydrotestosterone (DHT)1 receptor of rat ventral prostate. The competitive receptor assay used involves precipitation of the 105,000 X g supernatant of the homogenized tissue with protamine sulfate, removal of the unprecipitated cytosol, and incubation of the precipitate in the presence of the appropriate [3H]DHT steroid solution at 0 C for 18 hours. Using this method the Kd (dissociation constant) for DHT in the rat prostate was in the range of 1.9-4.0 X 10(-9)M and the binding capacity was 0.21 pmol/mg protein. Spironolactone was found to interfere with the binding of DHT to the precipitated cytosol and displayed an estimated Kd of 1.3-4.6 X 10(- 8)M. Several digitalis preparations were similarly studied. Digitoxin and digitoxigenin also interfered with the binding of [3H]DHT and had an estimated Kd of 0.8-3.6 X 10(-8)M. Digoxin interacted less strongly and its estimated Kd was 10(-6)M. We believe these results suggest an interaction of spironolactone and digitalis with the DHT receptor and may help explain some of their antiandrogenic actions in the rat and in man.


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
P. Ferrari, L. Torielli, M. Ferrandi, G. Padoani, L. Duzzi, M. Florio, F. Conti, P. Melloni, L. Vesci, N. Corsico, et al.
PST2238: A New Antihypertensive Compound That Antagonizes the Long-Term Pressor Effect of Ouabain
J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 83 - 94.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
S.-W. Wang, Y.-C. Chiao, S.-C. Tsai, C.-C. Lu, J.-J. Chen, H.-C. Shih, Y.-H. Chen, H. Lin, C.-M. Hwu, and P. S. Wang
Inhibition of Bufalin on Pituitary and Testicular Function in Rats
J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 528 - 532.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1975 by The Endocrine Society